Market Cap (In TWD)
643.37 Million
Revenue (In TWD)
22.74 Million
Net Income (In TWD)
-6.04 Million
Avg. Volume
226.14 Thousand
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 7.72-16.6
- PE
- -
- EPS
- -
- Beta Value
- -0.451
- ISIN
- TW0006549009
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Hung-Chang Yuan
- Employee Count
- -
- Website
- https://www.taiwanj.com
- Ipo Date
- 2015-10-21
- Details
- TaiwanJ Pharmaceuticals Co., Ltd., a specialty pharmaceutical company, develops and commercializes small molecules for chronic organ inflammation of metabolic, autoimmune, and infectious etiologies in Taiwan. The company also develops JKB-122 and JKB-121; and novel chemical entities for therapy to address chronic liver diseases and allergy/asthma. Its products target various diseases that include liver inflammation/liver fibrosis, non-alcoholic steatohepatitis, non-alcoholic fatty liver disease, autoimmune diseases, asthma, and atopic dermatitis. The company was incorporated in 2011 and is based in Zhubei, Taiwan.
More Stocks
-
GXAIGaxos.ai Inc.
GXAI
-
6625JALCO Holdings Inc.
6625
-
412540Jeil M&S Co., Ltd
412540
-
011150CJ Seafood Corporation
011150
-
002485Cedar Development Co., Ltd.
002485
-
RWCB
-
IDNT
-
6198